| GlaxoSmithKline AG - Zeffix, Lösung zum Einnehmen | | 54869 | | 01 | | Zeffix | | Lösung zum Einnehmen | | J05AF05 | | Lamivudine | | 24.03.1999 | | |
| | Composition | | lamivudinum 5 mg, saccharum 200 mg, propylenglycolum 20 mg, natrii citras dihydricus, acidum citricum, natrii hydroxidum aut acidum hydrochloridum, aqua, propylis parahydroxybenzoas 180 µg, E 218 1.5 mg, aromatica corresp. propylenglycolum 44.8 µg et alcohol benzylicus 0.02 µg, aromatica corresp. propylenglycolum 18.6 µg et alcohol benzylicus 0.01 µg, ad solutionem pro 1 ml corresp. natrium 2.94 mg. | | Packungsbestandteile | | Solution (oral) | | | | | | | | Active Agent | Dose |
|---|
| Lamivudine | 5 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Lamivudine | 5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Citric Acid | | | | Alcohol Benzylicus | 0.01 µg/ml | | | Aqua | | | | Aromatica | | | | E 218 | 1.5 mg/ml | conserv. | | Natrii Citras Dihydricus | | | | Natrii Hydroxidum aut Acidum Hydrochloridum | | | | Propylenglycol | 20 mg/ml | | | Propylis Parahydroxybenzoas | 180 µg/ml | | | Saccharum | 200 mg/ml | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 010 | 240 ml | 27.75 | 46.60 | A | SL | Yes |
|
|
